Literature DB >> 19125622

Tubulin-interactive natural products as anticancer agents.

David G I Kingston1.   

Abstract

This review provides an overview of the discovery, structures, and biological activities of anticancer natural products that act by inhibiting or promoting the assembly of tubulin to microtubules. The emphasis is on providing recent information on those compounds in clinical use or in advanced clinical trials. The vinca alkaloids, the combretastatins, NPI-2358, the halichondrin B analogue eribulin, dolastatin 10, noscapine, hemiasterlin, and rhizoxin are discussed as tubulin polymerization inhibitors, while the taxanes and the epothilones are the major classes of tubulin polymerization promoters presented, with brief treatments of discodermolide, eleutherobin, and laulimalide. The challenges and future directions of tubulin-interactive natural products-based drug discovery programs are also discussed briefly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19125622      PMCID: PMC2765517          DOI: 10.1021/np800568j

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  123 in total

1.  [Drugs from nature. The biology of taxane].

Authors:  Eckhard Leistner
Journal:  Pharm Unserer Zeit       Date:  2005

2.  EndoTAG-1. MediGene.

Authors:  Gunter Schuch
Journal:  Curr Opin Investig Drugs       Date:  2005-12

3.  Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells.

Authors:  K Ye; Y Ke; N Keshava; J Shanks; J A Kapp; R R Tekmal; J Petros; H C Joshi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 4.  Current development status of small-molecule vascular disrupting agents.

Authors:  David J Chaplin; Michael R Horsman; Dietmar W Siemann
Journal:  Curr Opin Investig Drugs       Date:  2006-06

5.  DHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II open-label multicenter trial.

Authors:  Miranda Payne; Paul Ellis; David Dunlop; Malcolm Ranson; Sarah Danson; Lee Schacter; Denis Talbot
Journal:  J Thorac Oncol       Date:  2006-11       Impact factor: 15.609

6.  Complex target-oriented total synthesis in the drug discovery process: the discovery of a highly promising family of second generation epothilones.

Authors:  Alexey Rivkin; Fumihiko Yoshimura; Ana E Gabarda; Ting-Chao Chou; Huajin Dong; William P Tong; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2003-03-12       Impact factor: 15.419

7.  Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.

Authors:  S L Mooberry; G Tien; A H Hernandez; A Plubrukarn; B S Davidson
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

Review 8.  Activity of epothilone B analogues ixabepilone and patupilone in hormone-refractory prostate cancer.

Authors:  David Lee
Journal:  Clin Prostate Cancer       Date:  2004-09

Review 9.  Protein nanoparticles as drug carriers in clinical medicine.

Authors:  Michael J Hawkins; Patrick Soon-Shiong; Neil Desai
Journal:  Adv Drug Deliv Rev       Date:  2008-02-07       Impact factor: 15.470

10.  Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.

Authors:  E ter Haar; R J Kowalski; E Hamel; C M Lin; R E Longley; S P Gunasekera; H S Rosenkranz; B W Day
Journal:  Biochemistry       Date:  1996-01-09       Impact factor: 3.162

View more
  68 in total

Review 1.  Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.

Authors:  Tobias A M Gulder; Bradley S Moore
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-03       Impact factor: 15.336

2.  Bioactive substances with anti-neoplastic efficacy from marine invertebrates: Porifera and Coelenterata.

Authors:  Peter Sima; Vaclav Vetvicka
Journal:  World J Clin Oncol       Date:  2011-11-10

3.  Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Delia Preti; Mojgan Aghazadeh Tabrizi; Andrea Brancale; Xian-Hua Fu; Jun Li; Su-Zhan Zhang; Ernest Hamel; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2011-12-21       Impact factor: 7.446

Review 4.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

5.  Antitumor agents. 284. New desmosdumotin B analogues with bicyclic B-ring as cytotoxic and antitubulin agents.

Authors:  Kyoko Nakagawa-Goto; Pei-Chi Wu; Chin-Yu Lai; Ernest Hamel; Hao Zhu; Liying Zhang; Takashi Kozaka; Emika Ohkoshi; Masuo Goto; Kenneth F Bastow; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2011-02-01       Impact factor: 7.446

6.  A simplified synthesis of novel dictyostatin analogues with in vitro activity against epothilone B-resistant cells and antiangiogenic activity in zebrafish embryos.

Authors:  Laura L Vollmer; Maria Jiménez; Daniel P Camarco; Wei Zhu; Hikmat N Daghestani; Raghavan Balachandran; Celeste E Reese; John S Lazo; Neil A Hukriede; Dennis P Curran; Billy W Day; Andreas Vogt
Journal:  Mol Cancer Ther       Date:  2011-04-13       Impact factor: 6.261

7.  Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.

Authors:  S Rath; J Liebl; R Fürst; A Ullrich; J L Burkhart; U Kazmaier; J Herrmann; Rolf Müller; M Günther; L Schreiner; E Wagner; A M Vollmar; S Zahler
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

8.  HMBA is a putative HSP70 activator stimulating HEXIM1 expression that is down-regulated by estrogen.

Authors:  Rati Lama; Chunfang Gan; Nethrie Idippily; Viharika Bobba; David Danielpour; Monica Montano; Bin Su
Journal:  J Steroid Biochem Mol Biol       Date:  2017-02-14       Impact factor: 4.292

9.  Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway.

Authors:  Bokyung Sung; Kwang Seok Ahn; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

10.  An efficient synthetic strategy for obtaining 4-methoxy carbon isotope labeled combretastatin A-4 phosphate and other Z-combretastatins.

Authors:  George R Pettit; Mathew D Minardi; Fiona Hogan; Pat M Price
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.